Pam Taub, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Esperion(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Amgen(MODEST), Medtronic(MODEST), Novartis Corporation(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Epirium Bio(SIGNIFICANT)

View Full Disclosure